Different Dosage Regimens of Rituximab in Primary Membranous Nephropathy Treatment: A Systematic Review
Yu Yi(Xuzhou Medical College), Qijun Wan(Shenzhen Second People's Hospital), Ricong Xu(Shenzhen Second People's Hospital), Zhijian Li(Sun Yat-sen University)
Cited by 4
Related Papers
Neutrophil Percentage-to-Albumin Ratio and Risk of Mortality in Patients on Peritoneal Dialysis
|Journal of Inflammation Research|2023|46
Homocysteine and Arterial Occlusive Diseases
|Advances in Cardiovascular Diseases|2003|11
Emerging role of Rituximab in adult minimal change disease: a narrative review of clinical evidence, biomarkers and future perspectives
|BMC Nephrology|2025|5
P2.04-54 Characteristic of MSI-H Lung Cancer Patients Identified with Targeted Next-Generation Sequencing
|Journal of Thoracic Oncology|2019|4
Label-Free Monitoring of Endometrial Cancer Progression Using Multiphoton Microscopy
|Annals of Biomedical Engineering|2024|4